ArticleOncoimmunology

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.

Renée C G de Bruin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.